| Literature DB >> 27160909 |
Lingyong Li1, Shao-Rui Chen1, Hong Chen1, Lei Wen1, Walter N Hittelman2, Jing-Dun Xie3, Hui-Lin Pan4.
Abstract
Chronic neuropathic pain is a debilitating condition that remains difficult to treat. Diminished synaptic inhibition by GABA and glycine and increased NMDA receptor (NMDAR) activity in the spinal dorsal horn are key mechanisms underlying neuropathic pain. However, the reciprocal relationship between synaptic inhibition and excitation in neuropathic pain is unclear. Here, we show that intrathecal delivery of K(+)-Cl(-) cotransporter-2 (KCC2) using lentiviral vectors produces a complete and long-lasting reversal of pain hypersensitivity induced by nerve injury. KCC2 gene transfer restores Cl(-) homeostasis disrupted by nerve injury in both spinal dorsal horn and primary sensory neurons. Remarkably, restoring Cl(-) homeostasis normalizes both presynaptic and postsynaptic NMDAR activity increased by nerve injury in the spinal dorsal horn. Our findings indicate that nerve injury recruits NMDAR-mediated signaling pathways through the disruption of Cl(-) homeostasis in spinal dorsal horn and primary sensory neurons. Lentiviral vector-mediated KCC2 expression is a promising gene therapy for the treatment of neuropathic pain.Entities:
Keywords: cation-chloride cotransporters; gene therapy; neuropathic pain; synaptic plasticity; synaptic transmission
Mesh:
Substances:
Year: 2016 PMID: 27160909 PMCID: PMC4871741 DOI: 10.1016/j.celrep.2016.04.039
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423